NCT03293134View on ClinicalTrials.gov

Clinical and Molecular Characterization of Cerebral Proliferative Vasculopathy

CompletedOBSERVATIONAL
Enrollment

25

Participants

Timeline

Start Date

July 8, 2013

Primary Completion Date

March 9, 2015

Study Completion Date

October 6, 2016

Conditions
Proliferative Vasculopathy
Trial Locations (1)

75006

Hôpital Necker Enfants Malades, APHP, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT03293134 - Clinical and Molecular Characterization of Cerebral Proliferative Vasculopathy | Biotech Hunter | Biotech Hunter